GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation

GlaxoSmithKline (GSK) wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. Reducing batch review time usually results in faster batch cycle time, meaning higher throughput at the production facility and faster cash-to-cash cycle time. AspenTech was selected for this process due to integration with other solutions, such as Aspen InfoPlus.21® and GSK’s existing plant automation software (DCS). The pilot project was a resounding success, reducing order preparation time by 95% and record review time by over 50%.

GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation

Why we collect this data:

AspenTech is collecting and may process your personal data for a variety of reasons related to our business and our ability to deliver the best possible products, customer support service and overall user experience. Accordingly, we may use your personal data to administer research surveys, to accurately deliver contracted services, to register you for events, to understand your preferences and to detect and prevent any fraudulent or unauthorized activities. Please refer to AspenTech’s Privacy and Security Policy, which is available here, for more information regarding our collection and processing of your personal data.

GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation

Hello . If this is not you

Thank you for downloading this resource

If your download did not begin click here